Contribution to in vitro screening of Egyptian plants for schistosomicidal activity.

PHARMACEUTICAL research; METHANOL; ANTHELMINTICS; BIOLOGICAL assay; PLANT extracts; PLANT species

Context: This study is a continuation of our previous work in which a bioassay screening of 346 methanol extracts from 281 Egyptian plant species was carried out for in vitro schistosomicidal activity. Objective: Another 309 methanol extracts from 278 plant species were subjected to the bioassay screening using the same technique on viable Schistosoma mansoni Sambon (Schistosomatidae) mature worms in specialized culture medium (Roswell Park Memorial Institute medium 1640) in a trial to discover a source for a schistosomiasis drug from Egyptian flora. Material and methods: The methanol plant extracts were tested in vitro against viable S. mansoni mature worms in culture medium. Viability of worms was examined after exposure to 100 μg/ml of the extract in the medium for 24 h. Negative (dimethyl sulfoxide) and positive (praziquantel) controls were simultaneously used. Extracts showing schistosomicidal activity were further subjected to determination of their (Lethal concentration) LC50 and LC90 values. Results: Confirmed in vitro antischistosomal activity was found in 42 extracts. Of these, 14 plant species possessed considerably high antischistosomal activity (LC50 ≤ 15 µg/ml), viz. Callistemon viminalis (Soland. Ex Gaertn) Cheel, C. rigidus R.Br., C. speciosus (Sims.) DC , C. citrinus Stapf , Eucalyptus citriodora Hook, E. rostrata Dehnh., Eugenia edulis Vell , E. javanica Lam syn. Syzygium samarangense (Blume) Merril , Melaleuca leucadendron (L.) L. , M. stypheloides Sm. (all belong to Myrtaceae) , Cryptostegia grandiflora R.Br. (Asclepiadaceae) , Zilla spinosa (L.) Prantl (Cruciferae), Ficus trijuja L. (Moraceae) and Fagonia mollis Delile (Zygophylacae). Discussion and conclusion: These species may represent additional natural sources of bioactive material that deserve further investigation for drug discovery against schistosomiasis. [ABSTRACT FROM AUTHOR]

Copyright of Pharmaceutical Biology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)